Your browser doesn't support javascript.
loading
Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.
Matuszak, Jasmin; Baumgartner, Jens; Zaloga, Jan; Juenet, Maya; da Silva, Acarília Eduardo; Franke, Danielle; Almer, Gunter; Texier, Isabelle; Faivre, Damien; Metselaar, Josbert M; Navarro, Fabrice P; Chauvierre, Cédric; Prassl, Ruth; Dézsi, László; Urbanics, Rudolf; Alexiou, Christoph; Mangge, Harald; Szebeni, János; Letourneur, Didier; Cicha, Iwona.
Afiliação
  • Matuszak J; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Baumgartner J; Department of Biomaterials, Max Planck Institute of Colloids & Interfaces, Science Park Golm, Potsdam, Germany.
  • Zaloga J; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Juenet M; Inserm U1148, LVTS, Paris Diderot University, Paris 13 University, Sorbonne Paris Cité, X. Bichat Hospital, Paris, France.
  • da Silva AE; Department of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands.
  • Franke D; nanoPET Pharma GmbH, Berlin, Germany.
  • Almer G; Clinical Institute of Medical & Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Texier I; CEA-LETI MINATEC/DTBS, Université Grenoble Alpes, Grenoble, France.
  • Faivre D; Department of Biomaterials, Max Planck Institute of Colloids & Interfaces, Science Park Golm, Potsdam, Germany.
  • Metselaar JM; Department of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands.
  • Navarro FP; Department of Experimental Molecular Imaging, University Clinic & Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany.
  • Chauvierre C; CEA-LETI MINATEC/DTBS, Université Grenoble Alpes, Grenoble, France.
  • Prassl R; Inserm U1148, LVTS, Paris Diderot University, Paris 13 University, Sorbonne Paris Cité, X. Bichat Hospital, Paris, France.
  • Dézsi L; Institute of Biophysics, Medical University of Graz, Graz, Austria.
  • Urbanics R; Nanomedicine Research & Education Center, Semmelweis University, Budapest, Hungary.
  • Alexiou C; SeroScience Ltd., Budapest, Hungary.
  • Mangge H; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Szebeni J; Clinical Institute of Medical & Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Letourneur D; Nanomedicine Research & Education Center, Semmelweis University, Budapest, Hungary.
  • Cicha I; SeroScience Ltd., Budapest, Hungary.
Nanomedicine (Lond) ; 11(6): 597-616, 2016 Mar.
Article em En | MEDLINE | ID: mdl-27003004
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2016 Tipo de documento: Article